Literature DB >> 16641246

CA150 expression delays striatal cell death in overexpression and knock-in conditions for mutant huntingtin neurotoxicity.

Margarita Arango1, Sébastien Holbert, Dania Zala, Emmanuel Brouillet, James Pearson, Etienne Régulier, Ashwani Kumar Thakur, Patrick Aebischer, Ronald Wetzel, Nicole Déglon, Christian Néri.   

Abstract

Transcriptional dysregulation caused by expanded polyglutamines (polyGlns) in huntingtin (htt) may be central to cell-autonomous mechanisms for neuronal cell death in Huntington's disease (HD) pathogenesis. We hypothesized that these mechanisms may involve the dysfunction of the transcriptional regulator CA150, a putative modifier of onset age in HD, because it binds to htt and accumulates in an HD grade-dependent manner in striatal and cortical neurons. Consistently, we report herein that CA150 expression rescues striatal cell death in lentiviral overexpression (rats) and knock-in (mouse cells) conditions for mutant htt neurotoxicity. In both systems, rescue was dependent on the (Gln-Ala)38 repeat normally found in CA150. We excluded the possibility that rescue may be caused by the (Gln-Ala)38 repeat interacting with polyGlns and, by doing so, blocking mutant htt toxicity. In contrast, we found the (Gln-Ala)38 repeat is required for the nuclear restriction of exogenous CA150, suggesting that rescue requires nuclear CA150. Additionally, we found the (Gln-Ala)38 repeat was dispensable for CA150 transcriptional repression ability, suggesting further that CA150 localization is critical to rescue. Finally, rescue was associated with increased neuritic aggregation, with no reduction of nuclear inclusions, suggesting the solubilization and nuclear export of mutant htt. Together, our data indicate that mutant htt may induce CA150 dysfunction in striatal neurons and suggest that the restoration of nuclear protein cooperativity may be neuroprotective.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16641246      PMCID: PMC6674076          DOI: 10.1523/JNEUROSCI.5409-05.2006

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  62 in total

1.  Solubilization and disaggregation of polyglutamine peptides.

Authors:  S Chen; R Wetzel
Journal:  Protein Sci       Date:  2001-04       Impact factor: 6.725

2.  Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity.

Authors:  F C Nucifora ; M Sasaki; M F Peters; H Huang; J K Cooper; M Yamada; H Takahashi; S Tsuji; J Troncoso; V L Dawson; T M Dawson; C A Ross
Journal:  Science       Date:  2001-03-23       Impact factor: 47.728

3.  Transcriptional cofactor CA150 regulates RNA polymerase II elongation in a TATA-box-dependent manner.

Authors:  C Suñé; M A Garcia-Blanco
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

4.  The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription.

Authors:  J S Steffan; A Kazantsev; O Spasic-Boskovic; M Greenwald; Y Z Zhu; H Gohler; E E Wanker; G P Bates; D E Housman; L M Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

Review 5.  Loss of normal huntingtin function: new developments in Huntington's disease research.

Authors:  E Cattaneo; D Rigamonti; D Goffredo; C Zuccato; F Squitieri; S Sipione
Journal:  Trends Neurosci       Date:  2001-03       Impact factor: 13.837

6.  Neurological abnormalities in a knock-in mouse model of Huntington's disease.

Authors:  C H Lin; S Tallaksen-Greene; W M Chien; J A Cearley; W S Jackson; A B Crouse; S Ren; X J Li; R L Albin; P J Detloff
Journal:  Hum Mol Genet       Date:  2001-01-15       Impact factor: 6.150

7.  Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease.

Authors:  N Déglon; J L Tseng; J C Bensadoun; A D Zurn; Y Arsenijevic; L Pereira de Almeida; R Zufferey; D Trono; P Aebischer
Journal:  Hum Gene Ther       Date:  2000-01-01       Impact factor: 5.695

8.  Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology.

Authors:  E Scherzinger; A Sittler; K Schweiger; V Heiser; R Lurz; R Hasenbank; G P Bates; H Lehrach; E E Wanker
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

9.  The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis.

Authors:  S Holbert; I Denghien; T Kiechle; A Rosenblatt; C Wellington; M R Hayden; R L Margolis; C A Ross; J Dausset; R J Ferrante; C Néri
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

10.  Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells.

Authors:  F Trettel; D Rigamonti; P Hilditch-Maguire; V C Wheeler; A H Sharp; F Persichetti; E Cattaneo; M E MacDonald
Journal:  Hum Mol Genet       Date:  2000-11-22       Impact factor: 6.150

View more
  23 in total

Review 1.  Physical chemistry of polyglutamine: intriguing tales of a monotonous sequence.

Authors:  Ronald Wetzel
Journal:  J Mol Biol       Date:  2012-01-27       Impact factor: 5.469

Review 2.  Image analysis tools for evaluation of microscopic views of immunohistochemically stained specimen in medical research-a review.

Authors:  Keerthana Prasad; Gopalakrishna K Prabhu
Journal:  J Med Syst       Date:  2011-05-17       Impact factor: 4.460

Review 3.  PolyQ disease: misfiring of a developmental cell death program?

Authors:  Elyse S Blum; Andrew R Schwendeman; Shai Shaham
Journal:  Trends Cell Biol       Date:  2012-12-08       Impact factor: 20.808

4.  Differential effects of sumoylation on transcription and alternative splicing by transcription elongation regulator 1 (TCERG1).

Authors:  Miguel Sánchez-Álvarez; Marta Montes; Noemí Sánchez-Hernández; Cristina Hernández-Munain; Carlos Suñé
Journal:  J Biol Chem       Date:  2010-03-09       Impact factor: 5.157

5.  Transcriptional Elongation Regulator 1 Affects Transcription and Splicing of Genes Associated with Cellular Morphology and Cytoskeleton Dynamics and Is Required for Neurite Outgrowth in Neuroblastoma Cells and Primary Neuronal Cultures.

Authors:  Juan Pablo Muñoz-Cobo; Noemí Sánchez-Hernández; Sara Gutiérrez; Younes El Yousfi; Marta Montes; Carme Gallego; Cristina Hernández-Munain; Carlos Suñé
Journal:  Mol Neurobiol       Date:  2016-11-14       Impact factor: 5.590

6.  Systems genetic analysis of multivariate response to iron deficiency in mice.

Authors:  Lina Yin; Erica L Unger; Leslie C Jellen; Christopher J Earley; Richard P Allen; Ann Tomaszewicz; James C Fleet; Byron C Jones
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-03-28       Impact factor: 3.619

Review 7.  Proteins Containing Expanded Polyglutamine Tracts and Neurodegenerative Disease.

Authors:  Adewale Adegbuyiro; Faezeh Sedighi; Albert W Pilkington; Sharon Groover; Justin Legleiter
Journal:  Biochemistry       Date:  2017-02-21       Impact factor: 3.162

8.  Integration of β-catenin, sirtuin, and FOXO signaling protects from mutant huntingtin toxicity.

Authors:  J Alex Parker; Rafael P Vazquez-Manrique; Cendrine Tourette; Francesca Farina; Nicolas Offner; Arnab Mukhopadhyay; Anne-Marie Orfila; Aurélie Darbois; Sophie Menet; Heidi A Tissenbaum; Christian Neri
Journal:  J Neurosci       Date:  2012-09-05       Impact factor: 6.167

9.  General structural motifs of amyloid protofilaments.

Authors:  Neil Ferguson; Johanna Becker; Henning Tidow; Sandra Tremmel; Timothy D Sharpe; Gerd Krause; Jeremy Flinders; Miriana Petrovich; John Berriman; Hartmut Oschkinat; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-23       Impact factor: 11.205

10.  Overexpression of Q-rich prion-like proteins suppresses polyQ cytotoxicity and alters the polyQ interactome.

Authors:  Leslie Ripaud; Victoria Chumakova; Matthias Antonin; Alex R Hastie; Stefan Pinkert; Roman Körner; Kiersten M Ruff; Rohit V Pappu; Daniel Hornburg; Matthias Mann; F Ulrich Hartl; Mark S Hipp
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.